Abstract | BACKGROUND: METHOD: Fourteen subjects who met DSM-IV criteria for sexual disorder NOS as well as criteria used by our research group for nonparaphilic compulsive sexual behavior and who had been treated with nefazodone were selected from patient charts at our clinic. The treating physician abstracted information from the charts regarding comorbid psychiatric conditions, medication, dosage, treatment response, and side effects. RESULTS: CONCLUSION: Results from this preliminary retrospective study suggest that nefazodone decreases the frequency of sexual obsessions and compulsions but does not produce the undesired sexual side effects caused by SSRI treatment.
|
Authors | E Coleman, T Gratzer, L Nesvacil, N C Raymond |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 61
Issue 4
Pg. 282-4
(Apr 2000)
ISSN: 0160-6689 [Print] United States |
PMID | 10830149
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antidepressive Agents, Second-Generation
- Piperazines
- Serotonin Uptake Inhibitors
- Triazoles
- nefazodone
|
Topics |
- Adult
- Aged
- Antidepressive Agents, Second-Generation
(therapeutic use)
- Comorbidity
- Disruptive, Impulse Control, and Conduct Disorders
(drug therapy, epidemiology, psychology)
- Humans
- Male
- Mental Disorders
(epidemiology)
- Middle Aged
- Minnesota
(epidemiology)
- Obsessive-Compulsive Disorder
(drug therapy, epidemiology, psychology)
- Paraphilic Disorders
(drug therapy, epidemiology, psychology)
- Piperazines
- Retrospective Studies
- Selective Serotonin Reuptake Inhibitors
(adverse effects, therapeutic use)
- Treatment Outcome
- Triazoles
(therapeutic use)
|